L1CAM and endometrial carcinoma: Kommoss et al. further published data on 452 molecularly classified endometrial carcinomas and L1CAM expression (clone 14.10, dilution 1:50, cutoff 10%); they also showed that L1CAM expression was most frequent in p53-mutant tumors [60].